American Century Companies Inc. Has $61.85 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

American Century Companies Inc. boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.8% in the second quarter, Holdings Channel.com reports. The firm owned 2,482,953 shares of the medical instruments supplier’s stock after purchasing an additional 179,119 shares during the quarter. American Century Companies Inc.’s holdings in DENTSPLY SIRONA were worth $61,850,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP boosted its holdings in DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after acquiring an additional 1,419,503 shares in the last quarter. Cooke & Bieler LP raised its position in shares of DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after purchasing an additional 1,046,105 shares during the period. Generation Investment Management LLP lifted its holdings in shares of DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after purchasing an additional 1,998,012 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after purchasing an additional 343,915 shares during the period. Finally, Champlain Investment Partners LLC increased its stake in DENTSPLY SIRONA by 11.3% during the 1st quarter. Champlain Investment Partners LLC now owns 4,290,737 shares of the medical instruments supplier’s stock valued at $142,410,000 after purchasing an additional 434,155 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $26.28 on Monday. DENTSPLY SIRONA Inc. has a 52-week low of $23.58 and a 52-week high of $37.60. The company has a fifty day moving average of $25.40 and a 200-day moving average of $28.09. The company has a market capitalization of $5.33 billion, a P/E ratio of -59.73, a P/E/G ratio of 1.22 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period last year, the firm earned $0.51 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on XRAY shares. Needham & Company LLC restated a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Evercore ISI cut their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Finally, Stifel Nicolaus cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $33.44.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.